Pure-Biomedical Announces Trading Information Disclosure Due to Securities Meeting Public Notice Standards, Releasing Major Financial and Business Information for Investor Clarity
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Pure-Biomedical is announcing major financial and business information as its securities have met the standards for public notice of trading information. The company released consolidated self-assessed figures for March 115, showing significant revenue growth, alongside audited figures for Q4 114 and the trailing four quarters, which indicate losses.